celltech group the independent biotechnology company halved pre-tax losses and intends to seek a listing for its shares by 1994 a loss of pounds 6.58 m pounds 12.5 m was incurred for the year to september 30, on turnover of pounds 17 m pounds 19.9 m the company has completed a restructuring programme and its research is now focused on projects aimed at large markets such as cancer therapy and transplant technology